Exactly. Seasoned investors/traders know this. As long as the science and company are moving forward, we're good. Not just good to see $IPIX progressing toward phase 3's but seeing a very impressive pipeline with NO FAILURES is just incredible imo.
My money is on this guy making it all happen for us for the first deal with brilacidin......
Arthur P. Bertolino, MD, PHD, MBA
President and Chief Medical Officer
Dr. Bertolino serves as President and Chief Medical Officer at Innovation. Dr. Bertolino is a leading pharmaceutical dermatology executive with over 15 years of domestic and global drug development and management experience. Previously, he was Vice President of Dermatology at Novartis, Vice President and Chief Medical Officer of Peplin, Inc., and Senior Director of Dermatology at Pfizer. Dr. Bertolino has authored over 50 abstracts, papers, and book chapters, and has been a regular on-air and in-print contributor to leading media companies. Dr. Bertolino received a BS (Chemistry / Biochemistry) degree from SUNY Stony Brook, an MD and PhD (Pharmacology) from The Johns Hopkins University School of Medicine, and an MBA from the University of Michigan Stephen M. Ross School of Business.
I agree. Set the news alerts and a few price alerts. High and low.